The Phosphatidylinositide 3′-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C1
Cancer Res (2001) 61 (22): 8203–8210.
Currently there are no citedby results. Try again later.
